|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Outcomes of submucosal(T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection显示文摘AIM To investigate the outcomes and recurrences of p T1 b esophageal adenocarcinoma(EAC) following endoscopic mucosal resection(EMR) and associated treatments.METHODS Patients undergoing EMR with pathologically confirmed T1 b EAC at two academic referral centers were retrospectively identified.Patients were divided into 4 groups based on treatment following EMR:Endoscopic therapy alone(group A),endoscopic therapy with either chemotherapy,radiation or both(group B),surgicalresection(group C) or no further treatment/lost to follow-up(<12 mo)(group D).Pathology specimens were reviewed by a central pathologist.Follow-up data was obtained from the academic centers,primary care physicians and/or referring physicians.Univariate analysis was performed to identify factors predicting recurrence of EAC.RESULTS Fifty-three patients with T1 b EAC underwent EMR,of which 32(60%) had adequate follow-up ≥ 12 mo(median 34 mo,range 12-103).There were 16 patients in group A,9 in group B,7 in group C and 21 in group D.Median follow-up in groups A to C was 34 mo(range 12-103).Recurrent EAC developed overall in 9 patients(28%) including 6(38%) in group A(median:21 mo,range:6-73),1(11%) in group B(median:30 mo,range:30-30) and 2(29%) in group C(median 21 mo,range:7-35.Six of 9 recurrences were local;of the 6 recurrences,5 were treated with endoscopy alone.No predictors of recurrence of EAC were identified.CONCLUSION Endoscopic therapy of T1 b EAC may be a reasonable strategy for a subset of patients including those either refusing or medically unfit for esophagectomy. | Darren D Ballard Neel Choksi Jingmei Lin Eun-Young Choi B Joseph Elmunzer Henry Appelman Douglas K Rex Hala Fatima William Kessler John M DeWitt | 2016 | World Journal of Gastrointestinal Endoscopy2016，8，20： | 2 |
| 2 | Biology of the chicken MHC(B complex)显示文摘 | Plachy J Pink J Hala K | 1992 | Critical Reviews in Immunolog1992，12，12： | 1 |
| 3 | Nomenclature for the chicken major histocompatibility (B and Y)complex显示文摘 | Miller M M Bacon L D Hala K | 2004 | Immunogenetics2004，56，： | 1 |
| 4 | Biology of the chicken MHC (Bcomplex)显示文摘 | J Plachy J R L Pink K Hala | 1992 | Critical Reviews in Immunolog1992，12，12： | 1 |
| 5 | Chicken-Activated-T-Lymphocyte-Antigen (CATLA) recognized by monoclonal antibody INN-CH 16 represents the IL-2 receptor显示文摘 | SCHAUENSTEIN K KROMER G HALA K | 1988 | Dev Immunol1988，12，4： | 1 |
| 6 | A Cellular Trojan Horse for delivery ofther apeutic nanoparticles into tumors显示文摘 | Choi M R Stanton - Maxey K J Stanley J K Levin C S Bardhan R Akin D Badve S Sturgis J Robinson J P Bashir B Halas H J and Clare S E | 2007 | Nano Letters2007，7，12： | 1 |
| 7 | Chicken-activated-T-lymphocyte-antigen(CATLA) recognized by monoclonal antibody INNCH 16 represents the IL-2 receptor 显示文摘 | Schauenstein K Kromer G Hala K | 1988 | Dev Comp Immunol1988，12，4： | 1 |
| 8 | Expression oF the vascular endothelial growth actor (VEGF) gene in epithelial ovarian canc- er: an approach to anti-VEGF therapy显示文摘 | Hala K Watanabe Y Nakai H | 2011 | Anticancer Res2011，31，2： | 1 |
| 9 | Sol-gel synthesis and characterization of nanostructured ZnO obtained in the ionic liquid[BMP]TFSA and in isopropanol显示文摘 | Farag Hala K | | 0，，： | 1 |
| 10 | Embryonic development of brown trout (Salmo trutta fario)显示文摘 | Halaka K | 1995 | Folia Zool1995，44，： | 1 |
| 11 | Expression of vascular endothelial growth factor in experimental choroidal neovascularization 显示文摘 | Ishibashi T Hala Y Yoshikawa H Nakagawa K Sueishi K Inomata H | 1997 | Graefe Arch Clin Exp Ophthalmol1997，235，3： | 1 |
| 12 | Streptomyces virginiae: Taxonomy, identification and biological activities 显示文摘 | Hala M Rifaat Amany L K | 2000 | Arab J Biotech2000，71，： | 1 |
| 13 | COMP acts as a catalyst in collagen fibrillogenesis显示文摘 | Hala'sz K Kassner A Morgelin M | 2007 | J Biol Chem2007，282，31： | 1 |
| 14 | Chicken-activated-T-lymphocyte-antigen(CATLA) recognized by monoclonal antibody INNCH 16 represents the IL-2 receptor 显示文摘 | Schauenstein K Kromer G Hala K | 1988 | Dev Comp Immunol1988，12，4： | 1 |
| 15 | Nomenclature for the chicken major histocompatibility (B and Y)complex显示文摘 | Miller M M Bacon L D Hala K etal | 2004 | Immunogenetics2004，56，： | 1 |
| 16 | 2004 nomenclature for the chicken major histocompatibility (B and Y) complex显示文摘 | Miller M M Bacon L D Hala K | 2004 | Immunogenetics2004，56，： | 1 |
| 17 | Nanoparti- cle-mediated coupling of light into a nanowire显示文摘 | Halas N J Knight M W Grady N K | 2007 | Nano Letters2007，7，8： | 1 |
| 18 | A three-locus model for the chicken major histocompatibility complex显示文摘 | Pink J R L Droege W Hala K | 1977 | Immunogenetics1977，5，： | 1 |
| 19 | Nomenclature for the chicken major histocompatibility (B and Y) complex显示文摘 | Miller M M Bacon L D Hala K | 2004 | Immunogenetics2004，56，： | 1 |
| 20 | Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors 显示文摘 | Eman M Khedr Sherifa A Hamed Hala K El - Shereef | 2009 | Neuropsychiatr Dis Treat2009，5，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员